MALAT1 and prostate carcinoma: In accord with this, MALAT1 depletion remarkably reduced 3D cell migration in 22RV1 (∼60%) and LNCaP (∼70%) cells compared with shSCRM controls (Fig. 2B), suggesting that MALAT1 is required for prostate cancer cell migration.